异基因造血干细胞移植是一种高风险的治疗过程。
Allogeneic stem cell transplant can be a high-risk procedure.
患者若接受异基因造血干细胞移植，则也可能会治愈。
Patients who have an allogeneic stem cell transplant may be cured.
异基因造血干细胞移植可用于治疗某些急性淋巴细胞白血病患者。
Allogeneic stem cell transplants are used to treat some ALL patients.
目的提高对异基因造血干细胞移植后早期深部真菌感染风险的认识。
Objective To understand the risk of invasive fungal infection at phase of preengraft- ment of allogeneic hematopoietic stem cell transplantation(HSCT).
卡泊芬净一线治疗异基因造血干细胞移植患者侵袭性真菌病是有效且可耐受的。
Caspofungin first-line therapy was effective and well tolerated in allogeneic hematopoietic SCT patients with mycologically documented IA.
异基因造血干细胞移植是目前唯一可以治愈慢粒的疗法，在年轻患者中尤为成功。
Allogeneic stem cell transplantation is the only treatment that can cure CML at this time. This treatment is most successful in younger patients.
目的：对ABO血型不合的异基因造血干细胞移植患者输血状况及血液成分选择进行探讨。
Objective: To explore the blood component selection and transfusion for patients undergoing major ABO incompatible allogenic stem cell transplantation.
结论更昔洛韦防治异基因造血干细胞移植术后CMV感染效果良好，早期诊断和治疗更为重要。
Conclusion: GCVshows good effect on prevention and treatment of CMV infection after allo-BMT, and an early diagnoses and early treatment is more important.
探讨了护理因素对异基因造血干细胞移植中abo血型主要不合和次要不合的干细胞输注的影响。
The nursing factors are detected which infect allogeneic peripheral blood haematopoietic stem cell infusion in ABO-major incompatible transplantation or ABO-minor incompatible transplantation.
若急粒患儿在接受了大剂量化疗后病情未见好转或病情复发，可采用异基因造血干细胞移植进行治疗。
Allogeneic stem cell transplants may be used in children who are not doing well or whose AML returns (called a relapse) after high-dose chemotherapy.
目的探讨TJU103对小鼠同种异基因造血干细胞移植模型移植物抗宿主病(GVHD)是否起预防作用。
Objective To explore the role of TJU103 in preventing graft-versus-host disease (GVHD) after allogeneic stem cell transplantation in mice.
目的探讨异基因造血干细胞移植(HSCT)后表现在肾脏的慢性移植物抗宿主病(GVHD)的临床及病理特点。
Objective to investigate the clinicopathologic characteristics of renal chronic graft versus host disease (GVHD) after allogeneic peripheral blood hematopoietic transplantation (HSCT).
结论TJU103不仅可以显著抑制体外t淋巴细胞增殖效应，而且可显著降低小鼠同种异基因造血干细胞移植模型GVHD的发生率。
Conclusion TJU103 is capable of markedly inhibiting t cell proliferative response in vitro and can decrease GVHD incidence after allogeneic stem cell transplantation in mice.
对200例异基因外周血造血干细胞移植患者护理措施进行总结和分析。
To summary and analyze the nursing methods of 200 patients received the allogeneic peripheral blood stem cell transplantation.
目的探讨非清髓异基因外周造血干细胞移植（NAST）在治疗高龄血液病中的作用。
Objective To study the role of nonmyeloablative allogeneic peripheral blood stem cell transplantation (NAST) in the treatment of hematological diseases in elderly patients.
目的探讨异基因外周血造血干细胞移植在肠型和极重度骨髓型放射病救治中的作用和地位。
Objective To explore the clinical significance of allogeneic peripheral stem cell transplantation in the treatment of acute radiation sickness.
对异基因外周血造血干细胞移植的猕猴，用Y特异性序列分析法和性别染色体检测法于移植后7及14天均检测到雄性供者嵌合。
Male donor chimerism were found on day 7 and 14 after allogeneic stem cell transplantation by Y-specific sequence and chromosome karyotype analysis.
进行异基因和自体造血干细胞移植，在无血缘关系或家庭成员捐助者，以及各种疾病适应症的比例在不同国家和地区间差异很大。
Use of allogeneic or autologous HSCT, unrelated or family donors for allogeneic HSCT, and proportions of disease indications varied significantly between countries and regions.
目的：以供体造血干细胞(HSC)诱导异基因大鼠肾脏移植免疫耐受，探讨免疫耐受的形成机制。
Objective: to induce immune tolerance to allogenic kidney transplantation with hematopoietic stem cells (HSC) in recipient rats and to study its mechanism.
目的：寻找促进异基因造血干细胞在致敏受者植入的策略研究，探讨抗cd 20单抗在致敏受者造血干细胞移植的作用。
AIM: to find a strategy for enhancing engraftment of hematopoietic stem cell in sensitized recipients and to study the effects of anti-CD20 antibody in hematopoietic stem cell transplantation.
本研究旨在探讨非清髓异基因外周血造血干细胞移植(NAPBSCT)后造血嵌合体的临床意义。
The aim of this study was to analyze the hematopoietic chimerism after non-myeloablative allogeneic peripheral blood stem cell transplantation (NAPBSCT).
尽早诊断、合理治疗；异基因外周血造血干细胞移植是提高该病患儿生存期的关键。
Early diagnosis and rational treatment, allogeneic hematopoietic stem cell transplantation in particular, are the key to the prolongation of survival time of children with erythroleukemia.
方法：25例急性白血病患者接受HLA相合同胞的异基因外周血造血干细胞移植，其中急性髓系白血病20例，急性淋巴细胞白血病5例。
METHODS: a total of 25 patients with acute leukemia received HLA-identical sibling allo-PBSCT. All cases included 20 cases with acute myeloid leukemia and 5 cases with acute lymphocytic leukemia.
方法：25例急性白血病患者接受HLA相合同胞的异基因外周血造血干细胞移植，其中急性髓系白血病20例，急性淋巴细胞白血病5例。
METHODS: a total of 25 patients with acute leukemia received HLA-identical sibling allo-PBSCT. All cases included 20 cases with acute myeloid leukemia and 5 cases with acute lymphocytic leukemia.
应用推荐